Journal Title：Therapeutics And Clinical Risk Management

Therapeutics and Clinical Risk Management is an international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas.

The journal welcomes submissions covering original research, clinical and epidemiological studies, reviews, guidelines, expert opinion and commentary. The journal will consider case reports but only if they make a valuable and original contribution to the literature.

As of 18th March 2019, Therapeutics and Clinical Risk Management will no longer consider meta-analyses for publication.

The journal does not accept study protocols, animal-based or cell line-based studies.

《治療與臨床風(fēng)險(xiǎn)管理》是一本國(guó)際同行評(píng)審的臨床治療和風(fēng)險(xiǎn)管理期刊，專注于簡(jiǎn)明快速地報(bào)告所有治療領(lǐng)域的臨床研究、結(jié)果、安全性以及有效、安全和持續(xù)使用藥物、治療和外科干預(yù)的計(jì)劃。

該期刊歡迎投稿，涵蓋原創(chuàng)研究、臨床和流行病學(xué)研究、評(píng)論、指南、專家意見(jiàn)和評(píng)論。該期刊將考慮病例報(bào)告，但前提是它們對(duì)文獻(xiàn)做出了有價(jià)值和原創(chuàng)的貢獻(xiàn)。

自 2019 年 3 月 18 日起，《治療與臨床風(fēng)險(xiǎn)管理》將不再考慮發(fā)表薈萃分析。

該期刊不接受研究方案、基于動(dòng)物或基于細(xì)胞系的研究。

Therapeutics And Clinical Risk Management創(chuàng)刊于2005年，由Dove Medical Press出版商出版，收稿方向涵蓋Pharmacology, Toxicology and Pharmaceutics - General Pharmacology, Toxicology and Pharmaceutics全領(lǐng)域，此刊是中等級(jí)別的SCI期刊，所以過(guò)審相對(duì)來(lái)講不是特別難，但是該刊專業(yè)認(rèn)可度不錯(cuò)，仍然是一本值得選擇的SCI期刊 。平均審稿速度 16 Weeks ，影響因子指數(shù)2.3，該期刊近期沒(méi)有被列入國(guó)際期刊預(yù)警名單，廣大學(xué)者值得一試。